# clm_0F41A2F44A01

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 1,026,800,000 United States dollar  
valid_from: 2025-09-30  
valid_to: 2026-03-31  
published: 2025-10-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_6BF4C3658A74  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly operating income: 1,026,800,000 United States dollar", as of 2025-09-30 (until 2026-03-31). Claim clm_0F41A2F44A01, https://asof.is/claim/clm_0F41A2F44A01, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm (primary, SEC EDGAR 10-Q Q3 FY2025, published 2025-10-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,079,500,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_0F41A2F44A01](/claim/clm_0F41A2F44A01.md) | [clm_0CA4006DEF0C](/claim/clm_0CA4006DEF0C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.